Your browser doesn't support javascript.
loading
Successful pregnancies in a patient with Takayasu arteritis and antiphospholipid syndrome, maintained on infliximab corticosteroid-free regimen: case-based review.
Jovicic, Zikica; Dragasevic, Sanja; Petkovic, Ana; Plesinac, Snezana; Sokic Milutinovic, Aleksandra; Stojanovic, Maja.
Afiliação
  • Jovicic Z; Clinic of Allergy and Immunology, University Clinical Center of Serbia, Koste Todorovica 2, 11000, Belgrade, Serbia.
  • Dragasevic S; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Petkovic A; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Plesinac S; Clinic for Gastroenterohepatology, University Clinical Center of Serbia, Belgrade, Serbia.
  • Sokic Milutinovic A; Department of Radiology, Center of Stereotaxic Radiosurgery, Clinic of Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia.
  • Stojanovic M; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Rheumatol Int ; 2023 Sep 01.
Article em En | MEDLINE | ID: mdl-37653060
Takayasu arteritis (TA) is a large vessel vasculitis affecting predominantly females below the age of 40. Patients with TA seem to be at increased risk for adverse pregnancy outcomes, resulting in mother or child complications. Although few studies analyzed the presence of antiphospholipid antibodies (APLA) in TA patients, an association between antiphospholipid syndrome (APS) and TA is rarely reported in the literature, mainly in the form of case reports. In fact, very few data regarding pregnancy outcomes in patients with TA and APS are available. An active form of Crohn's disease (CD) might be another risk factor strongly affecting the fertility rate. Here, we would like to present a 33-year-old woman with TA, double-positive APS and Crohn's disease (CD). The report is followed by the literature review of the association of APLA and/or APS with TA, focusing on analyzing the pregnancy outcomes. To our knowledge, this is the first case describing two successful, naturally occurring pregnancies, in a patient suffering from TA, APS and CD, and maintained on infliximab, azathioprine, and a corticosteroid-free regimen.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Rheumatol Int Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Rheumatol Int Ano de publicação: 2023 Tipo de documento: Article